COIN Coinbase Global, Inc.
Price Chart
Executive Summary
Barclays double downgraded the stock from Equal-Weight to Underweight on April 8, 2026, slashing its price target from $148 to $140, implying 27% downside from the current $192.96. This is a stark contrarian call against a heavily bullish consensus: 28 of 43 analysts rate it Buy or Strong Buy, with a mean target of $237.93 (+23% upside). Barclays has a 59% accuracy rate on 17 calls with an average return of 12.9%, ranking above average among covering firms. The downgrade comes amid a 30-day period with zero upgrades and zero downgrades from other firms, but EPS estimates have been revised down sharply — 6 downward revisions in the last 30 days for the current fiscal year, with the average EPS estimate falling from $3.71 to $2.72. Insider selling is heavy: Alesia J. Haas sold $2.0M in April and another $2.0M in March. Institutional activity is mixed: FMR LLC trimmed 70.6% of its position, while Norges Bank initiated a new $657M stake. Short interest is elevated at 56.3% of TRF volume. The bottom line: Barclays’ double downgrade is a high-conviction bearish signal that diverges sharply from consensus, but the firm’s track record is only modestly above average — traders should treat this as a cautionary flag rather than a definitive sell signal.
Impact Score
Consensus & Targets
Full consensus: 11 Strong Buy, 17 Buy, 12 Hold, 1 Sell, 2 Strong Sell — total 43 analysts. 65% are Buy/Strong Buy, 28% Hold, 7% Sell/Strong Sell. The consensus is overwhelmingly bullish, making Barclays' bearish call a stark outlier.
Current price: $192.96. Mean target: $237.93 (+23.3% upside). Median: $234. High: $400 (Citizens). Low: $115 (Barclays prior). Barclays' new PT of $140 is 41% below the mean and the second-lowest on the street, just above its own prior $107 target from May 8. The implied downside from current price is -27.4%.
Recent Analyst Activity
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-05-08 | Piper Sandler | maintain | Neutral | $170.00 |
| 2026-05-08 | Barclays | maintain | Underweight | $107.00 |
| 2026-05-08 | Needham | maintain | Buy | $220.00 |
| 2026-05-06 | Benchmark | maintain | Buy | $260.00 |
| 2026-05-06 | Rosenblatt | maintain | Buy | $240.00 |
| 2026-05-05 | JP Morgan | maintain | Overweight | $290.00 |
| 2026-04-21 | Cantor Fitzgerald | maintain | Overweight | $250.00 |
| 2026-04-15 | Piper Sandler | maintain | Neutral | $180.00 |
| 2026-04-10 | Citizens | maintain | Market Outperform | $355.00 |
| 2026-04-08 | Barclays | downgrade | Underweight | $140.00 |
30-day analyst activity: 0 upgrades, 0 downgrades (excluding Barclays). EPS revisions are sharply negative: current fiscal year EPS estimates have been revised down 6 times in 30 days, from $3.71 to $2.72 (-26.7%). Next quarter EPS estimates fell from $1.19 to $0.92 (-22.7%). The trend is clearly deteriorating.
Firm Track Record — Barclays
Barclays accuracy: 54% on 6761 calls | avg return: 3.9%
Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 15 firms with ≥5 scored calls.
| Firm | Accuracy | Calls | Avg Return | vs Average |
|---|---|---|---|---|
| Benchmark | 100% | 3/3 | 42.5% | top tier |
| Compass Point | 75% | 6/8 | 14% | top tier |
| Rosenblatt | 75% | 9/12 | 27.7% | top tier |
| Bernstein | 67% | 2/3 | 9.2% | top tier |
| Barclays | 59% | 10/17 | 12.9% | above average |
| B of A Securities | 55% | 6/11 | 1.5% | above average |
| Argus Research | 50% | 1/2 | -20.5% | below average |
| JP Morgan | 50% | 2/4 | 6.8% | below average |
| Jefferies | 50% | 1/2 | 4.9% | below average |
| Mizuho | 50% | 3/6 | 1.5% | below average |
Barclays has a 59% accuracy rate on 17 calls with an average return of 12.9%, ranking above average among covering firms. Top performers: Benchmark (100% on 3 calls, avg return +42.5%), Compass Point (75% on 8 calls, +14%), Rosenblatt (75% on 12 calls, +27.7%). Worst: Goldman Sachs (33% on 9 calls, -4.6%), Monness Crespi Hardt (33% on 3 calls, +11.9%). Barclays' track record is credible but not elite.
Earnings Estimates
Next earnings: Jul 29, 2026
| Period | EPS Est. | EPS Range | Revenue | Revisions (7d) |
|---|---|---|---|---|
| 0q | $0.48 | $-0.04 — $1.27 | $1.6B | ↑0 ↓0 |
| +1y | $4.75 | $2.00 — $8.38 | $8.3B | ↑0 ↓0 |
| +1q | $0.92 | $0.21 — $1.69 | $1.8B | ↑0 ↓0 |
| 0y | $2.72 | $0.66 — $5.19 | $6.9B | ↑0 ↓0 |
Cross-Platform Signals
Insider selling is heavy: Alesia J. Haas sold $2.0M in April, $2.0M in March, and another $2.0M in March. Two other insiders sold in February. Congressional trades show two small sells ($1K-$15K each) from both parties. Institutional activity is mixed: FMR LLC trimmed 70.6% ($280M), BofA trimmed 31.4% ($686M), while Norges Bank initiated a new $657M position and Wells Fargo doubled its stake (+168%, $606M). Short interest is elevated at 56.3% of TRF volume, indicating bearish positioning. The insider selling and short interest converge with Barclays' bearish view, but the large institutional buys diverge.
Actionable Insight
Barclays' double downgrade is a high-conviction bearish call that aligns with deteriorating EPS estimates and heavy insider selling, but diverges from a bullish consensus and mixed institutional flows. Traders should treat this as a cautionary flag — consider reducing exposure or hedging, but avoid outright shorting given the consensus tailwind and potential for a contrarian squeeze.
Documents Analyzed
Report based on filing metadata.
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 3, 2026
2d ago
|
Insider Cluster
| $164.13 $152.40 | ▼ −7.15% | ▼ −4.57% | $152.40 (−7.15%) |
|
Jun 1, 2026
4d ago
|
144
| $173.99 $163.22 | ▼ −6.19% | ▼ −5.47% | $152.40 (−12.41%) |
|
May 31, 2026
5d ago
|
ANALYST-UPGRADE
| $245.59 $240.78 | ▼ −1.96% | ▼ −2.61% | $152.40 (−37.95%) |
|
May 29, 2026
7d ago
|
Insider Cluster
| $182.61 $173.99 | ▼ −4.72% | ▼ −4.87% | $152.40 (−16.54%) |
|
May 20, 2026
16d ago
|
144
| $193.56 $184.99 | ▼ −4.43% | ▼ −4.87% | $152.40 (−21.26%) |
|
May 8, 2026
28d ago
|
ANALYST-DOWNGRADE
| $175.09 $169.02 | ▲ +3.47% | ▲ +4.04% | $152.40 (+12.96%) |
|
May 5, 2026
4w ago
|
8-K
| $197.75 $197.96 | ▲ +0.11% | ▼ −1.28% | $152.40 (−22.93%) |
|
May 1, 2026
5w ago
|
ANALYST-UPGRADE
| $245.59 $240.78 | ▼ −1.96% | ▼ −2.61% | $152.40 (−37.95%) |
|
Apr 24, 2026
6w ago
|
DEFA14A
| $196.68 $194.10 | ▼ −1.31% | ▼ −0.83% | $152.40 (−22.51%) |
|
Apr 16, 2026
7w ago
|
144
| $199.83 $206.33 | ▲ +3.25% | ▲ +2.04% | $152.40 (−23.74%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access